Simple skin test may reveal if brain shunts are working
NCT ID NCT04309383
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a device called ShuntCheck, which uses a mild heat sensor on the skin to see if a brain shunt is flowing properly. Researchers enrolled 12 adults with pseudotumor cerebri who had a shunt placed and were feeling well. The goal was to see if the device could correctly tell when the shunt was working or blocked, without needing X-rays or other tests.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ShuntCheck device
- What this could lead to
- If successful, this could provide a quick, non-invasive way to check if a shunt is working in pseudotumor cerebri patients, reducing the need for X-rays or scans.
- What could go wrong
- This was a very small study (12 people) and only looked at asymptomatic patients. The device may not be accurate in all cases or in patients with symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
12 people
The number who actually took part.
- Started
-
Oct 2019
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of asymptomatic PTC research subjects who have a VP shunt with a single ventricular catheter implanted for PTC and are visiting for routine care.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years old or older Adult men or women who possess a VP shunt placed for PTC; * Capable of providing valid signed informed consent, or has a legal guardian, health care agent, or surrogate decision maker (according to local statutes, and collectively referred to as "surrogates" in this protocol) capable of providing valid, signed informed consent; * Subjects will be asymptomatic visiting for routine care at 2-4 weeks post op Exclusion Criteria: * Presence of multiple shunts, or presence of more than one distal shunt catheter (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected obstruction; * ShuntCheck test would interfere with standard patient care, or emergency shunt surgery that cannot be delayed is indicated; * Presence of an interfering open wound or edema over any portion of the VP shunt.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pseudotumor cerebri are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of South Florida Department of Neurological Surgery and Brain Repair
Tampa, Florida, 33606, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.